- Tytuł:
- Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands.
- Autorzy:
- Źródło:
- International Journal of Breast Cancer. 9/22/2022, p1-12. 12p.
Czasopismo naukowe